Associated Papers
Protease inhibitor resistance analysis in the MONARK trial comparing first-line lopinavir-ritonavir monotherapy to lopinavir-ritonavir plus zidovudine and lamivudine triple therapy.
Delaugerre C et al.
Antimicrobial Agents and Chemotherapy, 2009
Select a paper to view details